• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳布啡在亚低温时的室间药代动力学。

Compartmental pharmacokinetics of nefopam during mild hypothermia.

机构信息

Department of Outcomes Research-E30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

出版信息

Br J Anaesth. 2012 May;108(5):784-91. doi: 10.1093/bja/aer517. Epub 2012 Feb 13.

DOI:10.1093/bja/aer517
PMID:22331396
Abstract

BACKGROUND

Nefopam is a non-opioid, non-steroidal, centrally acting analgesic which has an opioid-sparing effect. It also reduces the threshold (triggering core temperature) for shivering without causing sedation or respiratory depression. The drug is therefore useful as both an analgesic and to facilitate induction of therapeutic hypothermia. However, compartmental pharmacokinetics during hypothermia are lacking for nefopam.

METHODS

We conducted a prospective, randomized, blinded study in eight volunteers. On two different occasions, one of two nefopam concentrations was administered and more than 30 arterial blood samples were gathered during 12 h. Plasma concentrations were determined using gas chromatography/mass spectrometry to investigate the pharmacokinetics of nefopam with non-linear mixed-effect modelling.

RESULTS

A two-compartment mammillary model with moderate inter-individual variability and inter-occasional variability independent of covariates was found to best describe the data [mean (SE): V(1)=24.13 (2.8) litre; V(2)=183.34 (13.5) litre; Cl(el)=0.54 (0.07) litre min(-1); Cl(dist)=2.84 (0.42) litre min(-1)].

CONCLUSIONS

The compartmental data set describing a two-compartment model was determined and could be implemented to drive automated pumps. Thus, work load could be distributed to a pump establishing and maintaining any desired plasma concentration deemed necessary for a treatment with therapeutical hypothermia.

摘要

背景

奈福泮是一种非阿片类、非甾体类、中枢作用的镇痛药,具有阿片类药物的节省作用。它还降低了寒战的阈值(触发核心体温)而不引起镇静或呼吸抑制。因此,该药物既可用作镇痛药,也可用于促进治疗性低温的诱导。然而,奈福泮在低温时的房室药代动力学尚不清楚。

方法

我们在 8 名志愿者中进行了一项前瞻性、随机、双盲研究。在两种不同情况下,给予两种奈福泮浓度中的一种,并在 12 小时内采集了 30 多次动脉血样。使用气相色谱/质谱法测定血浆浓度,通过非线性混合效应模型研究奈福泮的药代动力学。

结果

发现一个具有中度个体间变异性和与协变量无关的偶发性变异性的两室乳突模型最能描述数据[平均(SE):V(1)=24.13(2.8)升;V(2)=183.34(13.5)升;Cl(el)=0.54(0.07)升分钟(-1);Cl(dist)=2.84(0.42)升分钟(-1)]。

结论

确定了描述两室模型的房室数据集,并可将其用于驱动自动泵。因此,可以将工作量分配给一个泵,该泵可以建立和维持任何认为对治疗性低温所需的理想血浆浓度。

相似文献

1
Compartmental pharmacokinetics of nefopam during mild hypothermia.纳布啡在亚低温时的室间药代动力学。
Br J Anaesth. 2012 May;108(5):784-91. doi: 10.1093/bja/aer517. Epub 2012 Feb 13.
2
The effects of nefopam on the gain and maximum intensity of shivering in healthy volunteers.奈福泮对健康志愿者寒战的增益和最大强度的影响。
Anesth Analg. 2010 Aug;111(2):409-14. doi: 10.1213/ANE.0b013e3181e332bb. Epub 2010 Jun 7.
3
Nefopam, a nonsedative benzoxazocine analgesic, selectively reduces the shivering threshold in unanesthetized subjects.奈福泮,一种非镇静性苯并恶唑嗪类镇痛药,可选择性降低未麻醉受试者的寒战阈值。
Anesthesiology. 2004 Jan;100(1):37-43. doi: 10.1097/00000542-200401000-00010.
4
Nefopam and meperidine are infra-additive on the shivering threshold in humans.奈福泮和哌替啶对人体寒战阈值的作用为低于相加效应。
Anesth Analg. 2014 Jul;119(1):58-63. doi: 10.1213/ANE.0000000000000193.
5
Effects of shivering prevention on haemodynamic and metabolic demands in hypothermic postoperative neurosurgical patients.预防寒颤对低温术后神经外科患者血流动力学及代谢需求的影响。
Anaesthesia. 2001 Jun;56(6):514-9. doi: 10.1046/j.1365-2044.2001.02057.x.
6
A Simultaneous Mixed-Effects Pharmacokinetic Model for Nefopam, N-desmethylnefopam, and Nefopam N-Oxide in Human Plasma and Urine.人血浆和尿液中奈福泮、N-去甲基奈福泮及奈福泮N-氧化物的同步混合效应药代动力学模型
Eur J Drug Metab Pharmacokinet. 2018 Aug;43(4):391-404. doi: 10.1007/s13318-017-0457-3.
7
Nefopam pharmacokinetics in patients with end-stage renal disease.终末期肾病患者奈福泮的药代动力学。
Anesth Analg. 2010 Nov;111(5):1146-53. doi: 10.1213/ANE.0b013e3181f33488.
8
A Randomized Clinical Trial of Nefopam versus Ketorolac Combined With Oxycodone in Patient-Controlled Analgesia after Gynecologic Surgery.奈福泮与酮咯酸联合羟考酮用于妇科手术后患者自控镇痛的随机临床试验
Int J Med Sci. 2015 Jul 30;12(8):644-9. doi: 10.7150/ijms.11828. eCollection 2015.
9
Nefopam and alfentanil additively reduce the shivering threshold in humans whereas nefopam and clonidine do not.奈福泮和阿芬太尼可相加降低人体的寒战阈值,而奈福泮和可乐定则不然。
Anesthesiology. 2009 Jul;111(1):102-9. doi: 10.1097/ALN.0b013e3181a979c1.
10
A comparison of nefopam and clonidine for the prevention of postanaesthetic shivering: a comparative, double-blind and placebo-controlled dose-ranging study.奈福泮与可乐定预防麻醉后寒战的比较:一项比较性、双盲、安慰剂对照的剂量范围研究。
Anaesthesia. 2004 Jun;59(6):559-64. doi: 10.1111/j.1365-2044.2004.03734.x.

引用本文的文献

1
A Simultaneous Mixed-Effects Pharmacokinetic Model for Nefopam, N-desmethylnefopam, and Nefopam N-Oxide in Human Plasma and Urine.人血浆和尿液中奈福泮、N-去甲基奈福泮及奈福泮N-氧化物的同步混合效应药代动力学模型
Eur J Drug Metab Pharmacokinet. 2018 Aug;43(4):391-404. doi: 10.1007/s13318-017-0457-3.
2
Development and statistical optimization of nefopam hydrochloride loaded nanospheres for neuropathic pain using Box-Behnken design.使用Box-Behnken设计法开发用于神经性疼痛的盐酸奈福泮负载纳米球并进行统计优化。
Saudi Pharm J. 2016 Sep;24(5):588-599. doi: 10.1016/j.jsps.2015.03.020. Epub 2015 Mar 25.
3
The Effect of Nefopam on Postoperative Fentanyl Consumption: A Randomized, Double-blind Study.
奈福泮对术后芬太尼用量的影响:一项随机双盲研究。
Korean J Pain. 2016 Apr;29(2):110-8. doi: 10.3344/kjp.2016.29.2.110. Epub 2016 Apr 1.
4
Nefopam Reduces Dysesthesia after Percutaneous Endoscopic Lumbar Discectomy.奈福泮可减轻经皮内镜下腰椎间盘切除术后的感觉异常。
Korean J Pain. 2016 Jan;29(1):40-7. doi: 10.3344/kjp.2016.29.1.40. Epub 2016 Jan 4.
5
Rediscovery of nefopam for the treatment of neuropathic pain.奈福泮治疗神经性疼痛的重新发现。
Korean J Pain. 2014 Apr;27(2):103-11. doi: 10.3344/kjp.2014.27.2.103. Epub 2014 Mar 28.
6
Population pharmacokinetics of nefopam in elderly, with or without renal impairment, and its link to treatment response.奈福泮在老年患者(无论有无肾功能损害)中的群体药代动力学及其与治疗反应的关联。
Br J Clin Pharmacol. 2014 Jun;77(6):1027-38. doi: 10.1111/bcp.12291.